AABB Welcomes New CABP Commission Members

April 16, 2025

AABB is pleased to welcome the newest members to the Certified Advanced Biotherapies Professional (CABP) Commission, an independent body entrusted with maintaining the rigor, fairness and relevance of AABB’s CABP Credentialing Program.

The CABP Commission is tasked with overseeing all aspects of the CABP certification process, including making key decisions related to certification eligibility, examination development and certification maintenance. To ensure the integrity and impartiality of the certification process, the commission also operates independently from AABB’s Board of Directors and any other organizational interests.

Commission members represent a broad range of stakeholder groups, including CABPs, physicians, laboratorians, researchers and professionals from regulatory, quality, hospital, blood center and biotech settings.

Mary McLeod, MT(ASCP)SBB, CABP(H), will serve as commission chair. She is joined by the following members:

Priya Baraniak, PhD
Wanxing Cui, MD, PhD, CABP(H)
Gina Drobena, MD, CABP
Raluca Dumitru, MD, PhD
Emily Hopewell, PhD, CABP
Colleen McLaughlin, DNP, CPNP
Linda Peltier, PhD, CABP
Lara Sarhan, BB(ASCP), CABP, CTBS, CQD, HCQP

AABB extends its gratitude to these individuals for their dedication to advancing excellence in biotherapies through their service on the CABP Commission.

Interested individuals can learn more about the CABP credential, including eligibility requirements, the exam’s seven key domains and available study resources, on AABB’s CABP web page.